Presentations by the top posters presented at the May 22 in person poster session.

1 min – welcome/intro, Laura van ‘t Veer

10 min (~8:30 AM) – Detection and Biomarkers Poster Winner Presentation
Serum Levels of Immune Markers Associated with Pathological Complete Response (pCR) and Immune-Related Adverse Events (irAEs) in Patients with Early-Stage Breast Cancer (BC) Receiving Neoadjuvant Immune Checkpoint Inhibitor Plus Chemotherapy in the I-SPY2 Trial
Silver Alkhafaji
3 min – Context (2 slides) Mike Campbell
7 min – Q & A

10 min (~8:50 AM) – Epidemiology and Population Science Poster Winner Presentation
Association Between Ancestry and Tumor Somatic Mutations Among Women with Breast Cancer
Kirkpatrick Fergus
3 min – Context (2 slides) Elad Ziv
7 min – Q & A

20 min (~9:10 AM) – Molecular and Cellular Biology two Poster Winner Presentations
10 min
Heterogeneity and Estrogen Receptor Activity in Tumor Organoids from the I-SPY Endocrine Optimization Protocol
Nadine Goldhammer
10 min
Elucidating the Role of small DNA Damage-associated RNAs (sdRNAs) in Breast Cancer Development
Jie Yu (presented by Jennifer Rosenbluth)
3 min – Context (2 slides) Andrei Goga
7 min – Q & A

10 min (~9:40) – Therapeutics and Clinical Trials Poster Winner Presentation
Intratumoral Injection of mRNA-2752 and PD-1 Inhibitor as a Treatment for High-Risk DCIS: Phase 1 Study Results (NCT02872025)
Kirithiga Ramalingam
3 min – Context (2 slides) Laurra Esserman
7 min – Q & A

1 min – Close, Laura van ‘t Veer